232 related articles for article (PubMed ID: 27216062)
1. Moxifloxacin Improves Treatment Outcomes in Patients with Ofloxacin-Resistant Multidrug-Resistant Tuberculosis.
Chien JY; Chien ST; Chiu WY; Yu CJ; Hsueh PR
Antimicrob Agents Chemother; 2016 Aug; 60(8):4708-16. PubMed ID: 27216062
[TBL] [Abstract][Full Text] [Related]
2. Mutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates.
Chien JY; Chiu WY; Chien ST; Chiang CJ; Yu CJ; Hsueh PR
Antimicrob Agents Chemother; 2016 Apr; 60(4):2090-6. PubMed ID: 26787695
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes and moxifloxacin susceptibility in ofloxacin-resistant multidrug-resistant tuberculosis.
Jo KW; Lee SD; Kim WS; Kim DS; Shim TS
Int J Tuberc Lung Dis; 2014 Jan; 18(1):39-43. PubMed ID: 24365550
[TBL] [Abstract][Full Text] [Related]
4. Limited Effect of Later-Generation Fluoroquinolones in the Treatment of Ofloxacin-Resistant and Moxifloxacin-Susceptible Multidrug-Resistant Tuberculosis.
Lee H; Ahn S; Hwang NY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Kim CK; Koh WJ
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203478
[TBL] [Abstract][Full Text] [Related]
5. Genotype analysis of ofloxacin-resistant multidrug-resistant
Gupta A; Sinha P; Rathod S; Shanmugam SK; Uma Devi KR; Anupurba S; Nema V
Indian J Med Res; 2020 Apr; 151(4):361-370. PubMed ID: 32461400
[TBL] [Abstract][Full Text] [Related]
6. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
[TBL] [Abstract][Full Text] [Related]
7. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T
J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
[TBL] [Abstract][Full Text] [Related]
8. Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin.
Nosova EY; Bukatina AA; Isaeva YD; Makarova MV; Galkina KY; Moroz AM
J Med Microbiol; 2013 Jan; 62(Pt 1):108-113. PubMed ID: 23019190
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin.
Singh P; Jain A; Dixit P; Prakash S; Jaiswal I; Venkatesh V; Singh M
J Antibiot (Tokyo); 2015 Jan; 68(1):63-6. PubMed ID: 25052485
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
[TBL] [Abstract][Full Text] [Related]
11. Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility.
Kam KM; Yip CW; Cheung TL; Tang HS; Leung OC; Chan MY
Microb Drug Resist; 2006; 12(1):7-11. PubMed ID: 16584301
[TBL] [Abstract][Full Text] [Related]
12. [Induction in vitro and stability of Mycobacterium tuberculosis resistance to ofloxacin].
Yang H; Hu Z; Sha W; Lu J; Cui Z; Wang J; Huang X; Xiao H
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Apr; 48(4):318-23. PubMed ID: 24969458
[TBL] [Abstract][Full Text] [Related]
13. Baseline resistance and cross-resistance among fluoroquinolones in multidrug-resistant Mycobacterium tuberculosis isolates at a national reference laboratory in India.
Mamatha HG; Shanthi V
J Glob Antimicrob Resist; 2018 Mar; 12():5-10. PubMed ID: 28887289
[TBL] [Abstract][Full Text] [Related]
14. Specific gyrA gene mutations predict poor treatment outcome in MDR-TB.
Rigouts L; Coeck N; Gumusboga M; de Rijk WB; Aung KJ; Hossain MA; Fissette K; Rieder HL; Meehan CJ; de Jong BC; Van Deun A
J Antimicrob Chemother; 2016 Feb; 71(2):314-23. PubMed ID: 26604243
[TBL] [Abstract][Full Text] [Related]
15. [Study on the resistance of rifampicin-resistant Mycobacterium tuberculosis to anti-tuberculosis drugs in group A].
Dai XW; Li CY; Wang NH; Chen SS; Tian LL; Zhao YF; Tao LY; Yang XY; Ding BC; He XX
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1110-1117. PubMed ID: 37914422
[No Abstract] [Full Text] [Related]
16.
Pang Y; Zong Z; Huo F; Jing W; Ma Y; Dong L; Li Y; Zhao L; Fu Y; Huang H
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739779
[TBL] [Abstract][Full Text] [Related]
17. Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model.
Poissy J; Aubry A; Fernandez C; Lott MC; Chauffour A; Jarlier V; Farinotti R; Veziris N
Antimicrob Agents Chemother; 2010 Nov; 54(11):4765-71. PubMed ID: 20805388
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolones for the treatment of tuberculosis in children.
Thee S; Garcia-Prats AJ; Donald PR; Hesseling AC; Schaaf HS
Tuberculosis (Edinb); 2015 May; 95(3):229-45. PubMed ID: 25797610
[TBL] [Abstract][Full Text] [Related]
19. Correlating clinical breakpoint concentration of moxifloxacin with gyrA mutations using the GenoType MTBDRsl assay Version 2.0.
Sidiq Z; Hanif M; Dwivedi KK; Chopra KK; Khanna A; Vashishat BK
Indian J Tuberc; 2023 Jul; 70(3):361-365. PubMed ID: 37562913
[TBL] [Abstract][Full Text] [Related]
20. Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China.
Chen J; Chen Z; Li Y; Xia W; Chen X; Chen T; Zhou L; Xu B; Xu S
Braz J Infect Dis; 2012; 16(2):136-41. PubMed ID: 22552454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
